| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.70B | 64.95B | 62.03B | 58.97B | 46.73B | 40.51B |
| Gross Profit | 9.07B | 8.21B | 7.98B | 7.60B | 6.63B | 6.10B |
| EBITDA | 2.78B | 2.25B | 2.28B | 1.92B | 1.30B | 1.44B |
| Net Income | 1.03B | 888.11M | 1.05B | 792.20M | 532.65M | 469.77M |
Balance Sheet | ||||||
| Total Assets | 41.09B | 39.23B | 36.68B | 36.17B | 30.85B | 27.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.13B | 4.15B | 5.30B | 5.19B | 4.26B | 4.83B |
| Total Debt | 13.01B | 12.37B | 11.02B | 12.13B | 8.95B | 7.67B |
| Total Liabilities | 26.95B | 25.33B | 23.44B | 22.87B | 18.09B | 14.93B |
| Stockholders Equity | 12.40B | 12.23B | 11.62B | 10.52B | 10.06B | 9.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.11B | 3.42B | -2.08B | -1.27B | 1.97B |
| Operating Cash Flow | 0.00 | -1.03B | 3.81B | -1.29B | -731.44M | 2.26B |
| Investing Cash Flow | 0.00 | -1.12B | -2.02B | -713.22M | -661.16M | -266.11M |
| Financing Cash Flow | 0.00 | 1.00B | -1.70B | 2.94B | 798.91M | -882.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥232.27B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥77.72B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
72 Outperform | ¥32.04B | 10.02 | ― | 1.23% | 6.74% | 29.20% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥10.15B | 4.86 | ― | 2.42% | 16.64% | 35.09% | |
52 Neutral | ¥31.13B | 48.79 | ― | 1.35% | 0.87% | -50.41% | |
49 Neutral | ¥64.67B | 32.06 | ― | 1.14% | 8.17% | 10.65% |